ONCOLYTICS BIOTECH INC - ONCY
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | — | P | A | 10,000.0 | 1.03 | 10,300.0 | 41,849.0 | View | |
| Mar 13, 2026 | Chief Executive Officer | P | A | 5,050.0 | 0.96 | 4,848.0 | 114,050.0 | View | |
| Feb 13, 2026 | — | P | A | 35,400.0 | 0.8557 | 30,291.78 | 78,128.0 | View | |
| Feb 13, 2026 | Chief Executive Officer | P | A | 29,500.0 | 0.842 | 24,839.0 | 109,000.0 | View | |
| Feb 13, 2026 | Chief Executive Officer | P | A | 5,600.0 | 0.836 | 4,681.6 | 79,500.0 | View | |
| Feb 13, 2026 | Chief Financial Officer | P | A | 12,000.0 | 0.842 | 10,104.0 | 287,515.0 | View | |
| Feb 13, 2026 | — | P | A | 30,000.0 | 0.8446 | 25,338.0 | 492,414.0 | View | |
| Feb 13, 2026 | Chief Medical Officer | P | A | 12,132.0 | 0.827 | 10,033.16 | 282,818.0 | View | |
| Feb 13, 2026 | — | P | A | 25,000.0 | 0.8496 | 21,240.0 | 109,851.0 | View | |
| Feb 13, 2026 | VP, Product Development | P | A | 10,000.0 | 0.8298 | 8,298.0 | 115,059.0 | View | |
| Feb 13, 2026 | — | P | A | 40,000.0 | 0.8466 | 33,864.0 | 566,991.0 | View | |
| Feb 13, 2026 | — | P | A | 60,000.0 | 0.8265 | 49,590.0 | 526,991.0 | View | |
| Feb 13, 2026 | Chief Business Officer | P | A | 29,600.0 | 0.8587 | 25,417.52 | 55,100.0 | View | |
| Jan 20, 2026 | — | P | A | 100,000.0 | 1.0377 | 103,770.0 | 466,991.0 | View |